Stem Cell Research Articles According to the FDA, Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) are used for the treatment of acute myocardial infarction, cardiomyopathies, critical limb ischemia, bronchopulmonary dysplasia in infants, HIV infection, diabetes mellitus types I and II, both acute and chronic liver diseases, autoimmune hepatitis, cirrhosis of various etiologies, ulcerative colitis, severe aplastic anemia, Alzheimer’s disease, systemic lupus erythematosus, rheumatoid arthritis, myelodysplastic syndrome, hereditary ataxia, spinal cord injury, ankylosing spondylitis, osteoarthritis, multiple sclerosis, Duchenne muscular dystrophy, acute and resistant to steroid therapy “graft versus host” reactions, and other diseases.
“The use of mesenchymal stem or stromal cells (MSCs) transplantation for tissue repair has received a great deal of attention in recent years, and these cells stand at the forefront of successful strategies in regenerative medicine.” Ryan, A., Murphy, M. and Barry, F. (2016)
Mesenchymal stem/stromal cell therapy, in The Biology and Therapeutic Application of Mesenchymal Cells (ed K. Atkinson), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118907474.ch29
“Superior to bone marrow stem cells (BM-MSCs), human umbilical cord blood mesenchymal stem cells (UC-MSCs) have significantly lower human leukocyte antigen expression, greater expansion capability and faster growth in vitro.” Lu Z, Zhao H, Xu J, Zhang Z, Zhang X, et al. (2013) Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Secondary Progressive Multiple Sclerosis.
J Stem Cell Res Ther S6:002. doi:10.4172/2157-7633.S6-002